Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 1—January 2012

Novel Prion Protein in BSE-affected Cattle, Switzerland

Torsten SeuberlichComments to Author , Michaela Gsponer, Cord Drögemüller, Miroslaw P. Polak, Sandra McCutcheon, Dagmar Heim, Anna Oevermann, and Andreas Zurbriggen
Author affiliations: University of Bern, Bern, Switzerland (T. Seuberlich, M. Gsponer, C. Drögemüller, A. Oevermann, A. Zurbriggen); National Veterinary Research Institute, Pulawy, Poland (M.P. Polak); University of Edinburgh, Edinburgh, Scotland, UK (S. McCutcheon); Federal Veterinary Office, Liebefeld, Switzerland (D. Heim)

Main Article


Figure. Molecular typing of the pathologic prion protein from 2 cows with bovine spongiform encepalopathy (BSE), Switzerland. Brain tissue homogenates of medulla oblongata from cows 1 and 2 and from controls with C-BSE (Switzerland), H-BSE, and L-BSE (Poland [2]), and a BSE-negative sample were treated with proteinase K, subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and blotted onto membranes according to the protocol of the Prionics AG (Schlieren, Switzerland) Check Western test. On the basis of the antibody binding results, the N terminus of the PrPres fragment in the samples from cows 1 and 2 lies between aa 111 and aa 154. Predicted PrPres fragments of C-BSE, H-BSE (PrPres 1 and 2), and L-BSE were adopted from the literature (2,6). A) Epitope mapping using antibodies 9A2, Sha31, 94B4, and JB10. B) Confirmatory Western blotting using antibody 6H4. C) Comparison PrPres in cow 2 and H-BSE with (+) and without (–) deglycosylation with PNGaseF (antibody 94B4, SDS-PAGE with NuPAGE MES instead of NuPAGE MOPS running buffer [Invitrogen, Carlsbad, CA, USA]). PrPres 1 and 2 in H-BSE samples are indicated. Molecular mass standards are shown in kiloDaltons. D) The illustration at the top represents the full-length, mature bovine prion protein and the binding sites of the antibodies used for epitope mapping (black boxes). N-terminal and C-terminal residues are indicated by numbers. PrPres fragments are partially mono- and di-glycosylated, which results in the characteristic 3-band patterns in the Western immunoblot. Sites of N-linked glycosylation are shown at positions 192 and 208 (-GlcNAc). C-BSE, classic BSE; cow 1, an 8-year-old BSE-positive cow; cow 2, a 15-year-old BSE-positive cow; PrPres, proteinase K–resistant fragment of the prion protein; H-BSE, atypical BSE with higher molecular mass of PrPres; L-BSE, atypical BSE with lower molecular mass of PrPres. Lane 1, C-BSE; lane 2, cow 1; lane 3, cow 2; lane 4, H-BSE; lane 5, L-BSE; lane 6, negative.

Main Article

  1. Colby  DW, Prusiner  SB. Prions. Cold Spring Harb Perspect Biol. 2011;3:a006833. DOIPubMedGoogle Scholar
  2. Jacobs  JG, Langeveld  JP, Biacabe  AG, Acutis  PL, Polak  MP, Gavier-Widen  D, Molecular discrimination of atypical bovine spongiform encephalopathy strains from a geographical region spanning a wide area in Europe. J Clin Microbiol. 2007;45:18219. DOIPubMedGoogle Scholar
  3. Seuberlich  T, Heim  D, Zurbriggen  A. Atypical transmissible spongiform encephalopathies in ruminants: a challenge for disease surveillance and control. J Vet Diagn Invest. 2010;22:82342. DOIPubMedGoogle Scholar
  4. Schaller  O, Fatzer  R, Stack  M, Clark  J, Cooley  W, Biffiger  K, Validation of a Western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE). Acta Neuropathol. 1999;98:43743. DOIPubMedGoogle Scholar
  5. Office Internationale des Epizooties. OIE rules for the official confirmation of BSE in bovines (based on an initial reactive result in an approved rapid test) by using a second rapid test. 2009 [cited 2011 Oct 19].
  6. Biacabe  AG, Jacobs  JG, Bencsik  A, Langeveld  JP, Baron  TG. H-type bovine spongiform encephalopathy: complex molecular features and similarities with human prion diseases. Prion. 2007;1:618. DOIPubMedGoogle Scholar

Main Article

Page created: December 22, 2011
Page updated: December 22, 2011
Page reviewed: December 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.